Koninklijke Philips N.V.
Netherlands · NL0000009538 · reports in EUR · Europe
The answers
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Is it growing?Fair
- Revenue −1.0% in the year to Dec 31, 2025, on the year before.
- Is it a good business?Fair
- It earned 8.2% on its shareholders' equity in the year to Dec 31, 2025.
- Is it safe?Fair
- Equity is 41% of its assets.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in EUR.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | €17.8B | €18.2B | €18.0B | €17.8B |
| Operating profit | −€1.5B | −€115M | €529M | €1.4B |
| Net profit to shareholders | −€1.6B | −€466M | −€702M | €895M |
| Earnings per share | −€1.75 | −€0.49 | −€0.75 | €0.94 |
| Dividend per share | €0.85 | n/a | €0.85 | €0.85 |
| Capital spending | €444M | €345M | €317M | €269M |
| Cash | €1.2B | €1.9B | €2.4B | €2.8B |
| Total assets | €30.7B | n/a | €29.0B | €26.9B |
| Equity | €13.3B | €12.1B | €12.0B | €11.0B |
What they do
In the company's own words, from the annual report.
Philips is a leading health technology company primarily involved in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.